Cancer de la prostate résistant à la castration (CRPC) : pourquoi XTANDI™ (enzalutamide) est-il un game changer ?

Authors
Publication date
1 January 2020
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    DIAL UCLouvain

    redirect
    oaioai:dial.uclouvain.be:boreal:2...
    Last time updated on 27/02/2021